According to a study published in The Pharmacogenomics Journal, Indians have a higher risk for medicine-induced heart-related cases compared with the West. The study also shows Indians’ varied responses to widely used medicines like warfarin(anti-coagulant drugs), metformin (diabetes drug), and clopidogrel (antiplatelet drug). The varied response to medicines among Indians highlights the significance of creating India-specific comprehensive pharmacogenomic data. MedicaMap covers common medicines like metformin, clopidogrel, warfarin, codeine, and many other medicines commonly used by Indians. MedicaMap gives an easy-to-read comprehensive report on medicines' toxicity and efficacy for a person. It helps clinicians to identify alternate medicine or adjust the dosage according to an individual’s genetic profile for the prevention, diagnosis, and treatment of any health condition. What isPharmacogenomics?
Pharmacogenetics is the study of how a person’s genetic makeup affects the metabolism of medications.  The more drugs the patient is taking the more likely the risk of an adverse drug reaction. Testing your DNA to determine how you 

metabolise medications can help your doctor to prescribe you the best medication and the right dose.

In the last decade, the use of pharmacogenomics significantly impacted treatment decisions for many patients, especially in major specialties like cardiology, oncology, diabetology, psychiatry, etc.